ReviewBiochemical Society transactions2026
Reprogramming the inactive X chromosome: dynamics and insights from the germline.
Review in Biochemical Society transactions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Escape from X-chromosome inactivation: from gene discovery to regulatory mechanisms.Biochemical Society transactions · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Germline reprogramming is an essential process that resets the epigenome prior to gamete formation. Primordial germ cells (PGCs), the progenitors of oocytes and spermatozoa, undergo extensive epigenetic remodelling during development, including genome-wide DNA demethylation, histone modification remodelling, and large-scale reorganisation of 3D genome architecture. In female mammals, an additional layer of epigenetic regulation occurs during PGC reprogramming: the reactivation of the inactive X chromosome, namely, X-chromosome reactivation (XCR). Female PGC precursors carry an inactive X chromosome to ensure dosage compensation prior to reprogramming. While X-chromosome inactivation has been extensively studied for decades, XCR has only more recently emerged as a focus of investigation, and its functional importance for germline development and reproduction remains unclear. XCR takes place along PGC differentiation, from early emergence to meiosis, and involves loss of the long non-coding RNA XIST/Xist coating, DNA demethylation at X-linked promoters, and re-expression of X-linked genes from the inactivated X. Sequential molecular events occurring during XCR have been characterised using both in vivo and in vitro approaches in a broad range of mammals from rodents to humans. In recent years, the emergence of low-input and single-cell omics technologies has substantially advanced our understanding of the inactive X-chromosome reactivation in the germline. In this review, we synthetise recent insights into XCR dynamics in mouse, human, and non-human primate PGCs. We discuss the remaining knowledge gaps and the future perspectives in the field of XCR and germline epigenetic reprogramming.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.